Literature DB >> 12271808

OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial.

M Nordentoft1, P Jeppesen, M Abel, P Kassow, L Petersen, A Thorup, G Krarup, R Hemmingsen, P Jørgensen.   

Abstract

BACKGROUND: Patients with first-episode psychosis comprise a high-risk group in terms of suicide. AIMS: To identify predictive factors for suicidal behaviour and to examine the effect of integrated treatment on suicidal behaviour and hopelessness.
METHOD: A total of 341 patients with a first-episode schizophrenia-spectrum disorder were randomised to integrated treatment or treatment as usual.
RESULTS: During the 1-year follow-up period, 11% attempted suicide. This was associated with female gender, hopelessness, hallucinations and suicide attempt reported at baseline, with the two latter variables being the only significant ones in the final multivariate model. The integrated treatment reduced hopelessness.
CONCLUSIONS: Hallucinations and suicide attempt before inclusion in the study were the most significant predictors of suicide attempt in the follow-up period.

Entities:  

Mesh:

Year:  2002        PMID: 12271808     DOI: 10.1192/bjp.181.43.s98

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  49 in total

Review 1.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  A comparison of correlates of suicidal ideation prior to initial hospitalization for first-episode psychosis with prior research on correlates of suicide attempts prior to initial treatment seeking.

Authors:  Peggy Flanagan; Michael T Compton
Journal:  Early Interv Psychiatry       Date:  2011-12-13       Impact factor: 2.732

3.  Suicidal behavior in adolescents with first-episode psychosis.

Authors:  Tatiana Falcone; Leenu Mishra; Erin Carlton; Catherine Lee; Robert S Butler; Damir Janigro; Barry Simon; Kathleen Franco
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-04

4.  Point-counterpoint: the importance of "open access" to psychotropics for our patients.

Authors:  Alan D Schmetzer; John J Wernert
Journal:  Psychiatr Q       Date:  2006

5.  The recognition and optimal management of early psychosis: an evidence-based reform.

Authors:  Patrick D McGorry
Journal:  World Psychiatry       Date:  2002-06       Impact factor: 49.548

6.  Did the introduction of 'dangerousness' and 'risk of harm' criteria in mental health laws increase the incidence of suicide in the United States of America?

Authors:  Matthew M Large; Olav B Nielssen; Steven M Lackersteen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-12-19       Impact factor: 4.328

7.  Antecedents and patterns of suicide behavior in first-admission psychosis.

Authors:  Shelly Bakst; Jonathan Rabinowitz; Evelyn J Bromet
Journal:  Schizophr Bull       Date:  2009-03-09       Impact factor: 9.306

8.  Contrasting monosymptomatic patients with hallucinations and delusions in first-episode psychosis patients: a five-year longitudinal follow-up study.

Authors:  Julie Evensen; Jan Ivar Røssberg; Ulrik Haahr; Wenche ten Velden Hegelstad; Inge Joa; Jan Olav Johannessen; Hans Langeveld; T K Larsen; Ingrid Melle; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Kjetil Sundet; Per Vaglum; Svein Friis; Thomas McGlashan
Journal:  Psychopathology       Date:  2011-01-13       Impact factor: 1.944

9.  The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis.

Authors:  Tom K J Craig; Philippa Garety; Paddy Power; Nikola Rahaman; Susannah Colbert; Miriam Fornells-Ambrojo; Graham Dunn
Journal:  BMJ       Date:  2004-10-14

10.  Characteristics of suicide attempters with family history of suicide attempt: a retrospective chart review.

Authors:  Makiko Nakagawa; Chiaki Kawanishi; Tomoki Yamada; Yoko Iwamoto; Ryoko Sato; Hana Hasegawa; Satoshi Morita; Toshinari Odawara; Yoshio Hirayasu
Journal:  BMC Psychiatry       Date:  2009-06-05       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.